PL4124336T3 - Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid - Google Patents

Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid

Info

Publication number
PL4124336T3
PL4124336T3 PL21188925.8T PL21188925T PL4124336T3 PL 4124336 T3 PL4124336 T3 PL 4124336T3 PL 21188925 T PL21188925 T PL 21188925T PL 4124336 T3 PL4124336 T3 PL 4124336T3
Authority
PL
Poland
Prior art keywords
cannabinoid
opioid
transmucosal patch
transmucosal
patch
Prior art date
Application number
PL21188925.8T
Other languages
English (en)
Inventor
Yvonne VON COBURG
Maike WINDBERGS
Viktoria Planz
Alice WALTHER
Nadine FREY
Anke SEIFERT
Marcel Walther
Original Assignee
Cannamedical Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cannamedical Pharma Gmbh filed Critical Cannamedical Pharma Gmbh
Publication of PL4124336T3 publication Critical patent/PL4124336T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL21188925.8T 2021-07-30 2021-07-30 Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid PL4124336T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21188925.8A EP4124336B1 (en) 2021-07-30 2021-07-30 Transmucosal patch comprising a cannabinoid and/or an opioid

Publications (1)

Publication Number Publication Date
PL4124336T3 true PL4124336T3 (pl) 2024-02-26

Family

ID=77168007

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21188925.8T PL4124336T3 (pl) 2021-07-30 2021-07-30 Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid

Country Status (9)

Country Link
EP (2) EP4124336B1 (pl)
KR (1) KR20240070510A (pl)
CN (1) CN118076344A (pl)
AU (1) AU2022318169A1 (pl)
CA (1) CA3226305A1 (pl)
ES (1) ES2962999T3 (pl)
IL (1) IL310490A (pl)
PL (1) PL4124336T3 (pl)
WO (1) WO2023006980A1 (pl)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80411A (en) 1986-10-24 1991-08-16 Raphael Mechoulam Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them
DE4100441A1 (de) 1991-01-09 1992-07-16 Mack Chem Pharm Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol
US5434295A (en) 1994-02-07 1995-07-18 Yissum Research Development Company Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds
DE69635048T2 (de) 1995-06-12 2006-02-16 G.D. Searle & Co. Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
GB0202385D0 (en) 2002-02-01 2002-03-20 Gw Pharma Ltd Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
GB2414933B (en) 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
TWI366460B (en) 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
US10052291B2 (en) * 2014-06-10 2018-08-21 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific doses of an active substance to skin or mucosa
CA2992923C (en) 2014-07-21 2021-06-29 Pharmaceutical Productions, Inc. Solid dosage form composition for buccal and sublingual administration of cannabinoids
CA2993377C (en) * 2015-11-19 2019-11-12 Dermtreat Aps A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
US10653640B2 (en) 2016-10-11 2020-05-19 Gbs Global Biopharma, Inc. Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseases
EP3634452A4 (en) * 2017-05-13 2020-06-03 Alvit LCS Pharma Ltd. SUBLINGUAL CANNABINOID COMPOSITIONS
EP3641727A1 (en) 2017-06-23 2020-04-29 MedCan Pharma A/S Cannabinoid pouch
EP3641726A1 (en) 2017-06-23 2020-04-29 MedCan Pharma A/S Cannabinoid pouch
EP3681525A4 (en) 2017-09-15 2020-09-02 Zelda Therapeutics Operations Pty Ltd COMPOSITION AND METHOD OF PROCESSING AUTISM

Also Published As

Publication number Publication date
KR20240070510A (ko) 2024-05-21
CA3226305A1 (en) 2023-02-02
CN118076344A (zh) 2024-05-24
EP4124336C0 (en) 2023-10-25
AU2022318169A1 (en) 2024-01-25
ES2962999T3 (es) 2024-03-22
EP4124336A1 (en) 2023-02-01
EP4376817A1 (en) 2024-06-05
WO2023006980A1 (en) 2023-02-02
EP4124336B1 (en) 2023-10-25
IL310490A (en) 2024-03-01

Similar Documents

Publication Publication Date Title
EP3815347A4 (en) ANTENNA STRUCTURE AND ELECTRONIC DEVICE INCLUDING AN ANTENNA
EP3695461A4 (en) ANTENNA STRUCTURE AND ELECTRONIC DEVICE INCLUDING AN ANTENNA STRUCTURE
EP4262025A4 (en) ANTENNA SYSTEM AND ELECTRONIC DEVICE
IL286374A (en) Cancer treatment containing naltrexone and cannabinoid
EP4016268A4 (en) KEY INDICATION METHOD AND ELECTRONIC DEVICE
EP4136705A4 (en) ELECTRONIC DEVICE WITH ANTENNA
EP3975333A4 (en) ANTENNA UNIT AND ELECTRONIC DEVICE
EP4170474A4 (en) DISPLAY METHOD, DEVICE AND ELECTRONIC DEVICE
EP3993159A4 (en) ANTENNA AND ELECTRONIC DEVICE COMPRISING IT
EP4145630A4 (en) MULTI-FREQUENCY DOUBLE POLARIZATION ANTENNA AND ELECTRONIC DEVICE
EP4007067A4 (en) ANTENNA UNIT AND ELECTRONIC DEVICE
GB202000221D0 (en) Electronic aerosol provision system
EP4123828A4 (en) ANTENNA UNIT AND ELECTRONIC DEVICE
EP4152517A4 (en) TERMINAL ANTENNA AND ELECTRONIC TERMINAL DEVICE
EP3975336A4 (en) ANTENNA UNIT AND ELECTRONIC DEVICE
IL310490A (en) A transmucosal patch that includes cannabinoids and/or an opioid
GB202003961D0 (en) Electronic aerosol provision system
EP4258472A4 (en) ANTENNA AND ELECTRONIC DEVICE
EP4175063A4 (en) ANTENNAS AND ELECTRONIC DEVICE THEREOF
EP4175065A4 (en) ANTENNA DEVICE, AND ELECTRONIC APPARATUS
EP4033608A4 (en) ANTENNA STRUCTURE AND ELECTRONIC DEVICE COMPRISING IT
GB202018721D0 (en) Electronic Aerosol Provision System
EP4246715A4 (en) ANTENNA AND ELECTRONIC DEVICE INCLUDING SAME
EP4246714A4 (en) ANTENNA AND ELECTRONIC DEVICE INCLUDING SAME
EP4250483A4 (en) ELECTRONIC DEVICE INCLUDING AN ANTENNA